Edition:
United States

Kalvista Pharmaceuticals Inc (KALV.A)

KALV.A on American Stock Exchange

20.62USD
25 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$20.62
Open
--
Day's High
--
Day's Low
--
Volume
100
Avg. Vol
333
52-wk High
$30.71
52-wk Low
$8.00

About

KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein... (more)

Overall

Beta: --
Market Cap(Mil.): $70.42
Shares Outstanding(Mil.): 9.71
Dividend: --
Yield (%): --

Financials

  KALV.A Industry Sector
P/E (TTM): -- 29.30 32.55
EPS (TTM): -3.21 -- --
ROI: -60.80 14.23 13.82
ROE: -61.05 15.46 15.24

Earnings vs. Estimates